Walsh Named One of the Top Law Firms Representing Pharmaceutical Companies in ANDA Suits
The fourth annual Hatch-Waxman/Abbreviated New Drug Application (ANDA) litigation report was released by Lex Machina on May 3, 2018. As part of the report, the top law firms in the country representing both plaintiffs and defendants were listed and Walsh Pizzi O’Reilly Falanga LLP (Walsh) was included along with some of the largest law firms in the country.
In its press release for the latest report, Lex Machina’s Chief Evangelist and General Counsel, Owen Byrd stated:
“Lex Machina’s latest Hatch-Waxman/ANDA Litigation Report provides pharmaceutical companies and their law firms with invaluable, data-driven insights about the legal matters, key participants, case timings and resolutions that can shape or reshape business and legal strategies . . . It also explores trends pertaining to top ANDA judges, parties and law firms, which can help litigators prepare legal strategies, select the best outside counsel and forecast litigation costs.”
When asked about the report, Liza Walsh, managing partner of the majority women-owned law firm said:
“Walsh lawyers strive to provide what matters most to our clients, namely, high-quality, sophisticated legal services, provided with personal attention and responsiveness. We are grateful to be included among such great firms.”
Based in Newark, New Jersey with additional offices located in New York City and Philadelphia, Walsh is comprised of a team of seasoned attorneys bringing together over 150 years of combined experience in a law firm poised to deliver high-quality, sophisticated legal services. For more information about Walsh, please contact Liza M. Walsh at (973)757-1100 or at firstname.lastname@example.org